Twin Health
PrivateLast Round
Series F
Jun 29, 2026
Est. Valuation
$950M
Total Funding Raised
$286.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Twin Health operates in Healthcare & Life Sciences and is based in Mountain View, California. Its latest recorded funding round was a Series E round in August 2025.
Twin Health is a health technology company that offers a precision health platform utilizing artificial intelligence and a digital twin model to assess, manage, and reverse chronic metabolic diseases like type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Patient Engagement, Health IoT, Telemedicine
Business Model
B2B2C
Customer Profile
Subscription SaaS, Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Twin Health Comparables
Compare Twin Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Virta Health | 88% | |
| Lark Health | 84% | |
| Omada Health, Inc. | 84% |
For institutional investors. Book with your work email.
Twin Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Jun 29, 2026 | ||||
| Series E | Aug 22, 2025 | ||||
| Series D | Dec 13, 2023 | ||||
| Series C | Oct 6, 2021 | ||||
| Series B | Oct 16, 2020 | ||||
Series A | Jun 17, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Twin Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series E, Series D |
| ICONIQ Capital | Series D, Series E |
| Perceptive Advisors | Series C |
| Peak XV Partners | Series D, Series C |
| ICONIQ Growth | Series D, Series E, Series C |
| Corner Ventures | Series C |
| LTS Investments | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2026
Named one of Newsweek’s Top Most Loved Workplace®.
- Jul 7, 2026
Named Innovator of the Year by EHIR.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_valuationNov 4, 2026
The 2026 index reports that Twin Health's valuation more than triples to exceed $2B in India.
For institutional investors. Book with your work email.
Twin Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Twin Health's valuation, stock price, and market status.
Is Twin Health a public or private company?
Twin Health is a private company.
What is the current stock price of Twin Health?
Twin Health is a private company, so its shares have no public market price. Caplight tracks Twin Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Twin Health worth (valuation)?
Twin Health's valuation is estimated at $950.0M based on funding round data.
Can I buy Twin Health stock?
Twin Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Twin Health's last funding round?
Twin Health's most recent funding round was Series F on June 29, 2026.
Who are the main investors in Twin Health?
Key investors in Twin Health include Temasek, ICONIQ Growth, Sequoia Capital, Maj Invest, DAG Ventures.
Will Twin Health IPO soon?
No public IPO plans have been announced for Twin Health.
How can I track Twin Health secondary market activity?
Caplight tracks bids, offers, and trades in Twin Health's shares on secondary markets.